IBISWorld Platform
Answer any industry question in minutes with our entire database at your fingertips.
Pharmaceutical Product Manufacturing in Australia Industry Data and Analysis
Favourable demand factors have supported demand for pharmaceutical products, including an ageing population and a greater incidence of chronic disease. Increased local and global demand for consumer healthcare products has also benefited several manufacturers. Even so, ongoing challenges have constrained revenue, including a changing regulatory and risk environment and reform-driven pricing pressures. Ongoing PBS reforms have heavily influenced manufacturers, as mandatory price disclosures and a greater reliance on generic drugs have continued to reduce prices and added to downwards pressures to profitability.
Access this data your way
The Pharmaceutical Product Manufacturing in Australia Industry analysis is available in multiple formats to fit seamlessly into your workflow.
API Data Delivery
Feed trusted, human-driven industry intelligence straight into your platform.
Integrations
Streamline your workflow with IBISWorld’s intelligence built into your toolkit.
What's included in this industry analysis
IBISWorld's research coverage on the Pharmaceutical Product Manufacturing industry in Australia includes market sizing, forecasting, data and analysis from 2015-2030. The most recent publication was released June 2025.
About this industry
What's this industry report about?
The Pharmaceutical Product Manufacturing industry in Australia operates under the ANZSIC industry code C1841. The industry comprises companies that manufacture medicinal and pharmaceutical products for human use from both synthetic (chemical) and natural sources. Other products include chemical or diagnostic testing agents, blood serums and biotech products. Industry activities include manufacturing active pharmaceutical ingredients and synthesising chemical ingredients, late-stage packaging and fill-finish activities. Related terms covered in the Pharmaceutical Product Manufacturing industry in Australia include over-the-counter (otc), blockbuster drugs, price disclosure reforms, biosimilars and patent cliff.
What's included in this industry?
Products and services covered in Pharmaceutical Product Manufacturing industry in Australia include Benefit-paid pharmaceuticals, Non-benefit-paid pharmaceuticals and OTC and complementary medicines.
What companies are included in this industry?
Companies covered in the Pharmaceutical Product Manufacturing industry in Australia include AstraZeneca Holdings, Aspen Pharma and Viatris.
Performance
What's included in the Performance chapter?
The Performance chapter covers detailed analysis, datasets, detailed current performance, sources of volatility and an outlook with forecasts for the Pharmaceutical Product Manufacturing industry in Australia.
Questions answered in this chapter include what's driving current industry performance, what influences industry volatility, how do successful businesses overcome volatility, what's driving the industry outlook. This analysis is supported with data and statistics on industry revenues, costs, profits, businesses and employees.
Products & Markets
What's included in the Products and Markets chapter?
The Products and Markets chapter covers detailed product and service segmentation, analysis of major markets and international trade data for the for the Pharmaceutical Product Manufacturing industry in Australia.
Questions answered in this chapter include how are the industry's products and services performing, what are innovations in industry products and services, what products or services do successful businesses offer and what's influencing demand from the industry's markets. This includes data and statistics on industry revenues by product and service segmentation and major markets.
Geographic Breakdown
What's included in the Geographic Breakdown chapter?
The Geographic Breakdown chapter covers detailed analysis and datasets on regional performance of the Pharmaceutical Product Manufacturing industry in Australia.
Questions answered in this chapter include where are industry businesses located and how do businesses use location to their advantage. This includes data and statistics on industry revenues by location.
Competitive Forces
What's included in the Competitive Forces chapter?
The Competitive Forces chapter covers the concentration, barriers to entry and supplier and buyer profiles in the Pharmaceutical Product Manufacturing industry in Australia. This includes data and statistics on industry market share concentration, barriers to entry, substitute products and buyer & supplier power.
Questions answered in this chapter include what impacts the industry's market share concentration, how do successful businesses handle concentration, what challenges do potential industry entrants face, how can potential entrants overcome barriers to entry, what are substitutes for industry services, how do successful businesses compete with substitutes and what power do buyers and suppliers have over the industry and how do successful businesses manage buyer & supplier power.
Companies
What's included in the Companies chapter?
The Companies chapter covers Key Takeaways, Market Share and Companies in the Pharmaceutical Product Manufacturing industry in Australia. This includes data and analysis on companies operating in the industry that hold a market share greater than 5%.
Questions answered in this chapter include what companies have a meaningful market share and how each company is performing.
External Environment
What's included in the External Environment chapter?
The External Environment chapter covers Key Takeaways, External Drivers, Regulation & Policy and Assistance in the Pharmaceutical Product Manufacturing industry in Australia. This includes data and statistics on factors impacting industry revenue such as economic indicators, regulation, policy and assistance programs.
Questions answered in this chapter include what demographic and macroeconomic factors impact the industry, what regulations impact the industry, what assistance is available to this industry.
Financial Benchmarks
What's included in the Financial Benchmarks chapter?
The Financial Benchmarks chapter covers Key Takeaways, Cost Structure, Financial Ratios, Valuation Multiples and Key Ratios in the Pharmaceutical Product Manufacturing industry in Australia. This includes financial data and statistics on industry performance including key cost inputs, profitability, key financial ratios and enterprise value multiples.
Questions answered in this chapter include what trends impact industry costs and how financial ratios have changed overtime.
Industry Data
What's included in the Industry Data chapter?
The Industry Data chapter includes 10 years of historical data with 5 years of forecast data covering statistics like revenue, industry value add, establishments, enterprises, employment and wages in the Pharmaceutical Product Manufacturing industry in Australia.
Trusted by industry professionals
More than 6,000 businesses use IBISWorld to shape local and global economies
We were able to supplement our reports with IBISWorld’s information from both a qualitative and quantitative standpoint. All of our reporting now features some level of IBISWorld integration.
IBISWorld delivers the crisp business knowledge we need to drive our business. Whether it be serving up our major clients, winning new business or educating on industry issues, IBISWorld brings real value.
IBISWorld has revolutionised business information — which has proved commercially invaluable to exporters, investors and public policy professionals in Australia and overseas.
When you’re able to speak to clients and be knowledgeable about what they do and the state that they operate in, they’re going to trust you a lot more.
Frequently Asked Questions
What is the market size of the Pharmaceutical Product Manufacturing industry in Australia in 2026?
The market size of the Pharmaceutical Product Manufacturing industry in Australia is $13.0bn in 2026.
How many businesses are there in the Pharmaceutical Product Manufacturing industry in Australia in 2025?
There are 580 businesses in the Pharmaceutical Product Manufacturing industry in Australia, which has grown at a CAGR of 4.2 % between 2020 and 2025.
How may import tariffs affect the Pharmaceutical Product Manufacturing industry in Australia?
The Pharmaceutical Product Manufacturing industry in Australia is likely to be significantly impacted by import tariffs with imports accounting for a high share of industry revenue.
How may export tariffs affect the Pharmaceutical Product Manufacturing industry in Australia?
The Pharmaceutical Product Manufacturing industry in Australia is likely to be significantly impacted by export tariffs with exports accounting for a high share of industry revenue.
Has the Pharmaceutical Product Manufacturing industry in Australia grown or declined over the past 5 years?
The market size of the Pharmaceutical Product Manufacturing industry in Australia has been declining at a CAGR of 1.4 % between 2020 and 2025.
What is the forecast growth of the Pharmaceutical Product Manufacturing industry in Australia over the next 5 years?
Over the next five years, the Pharmaceutical Product Manufacturing industry in Australia is expected to grow.
What are the biggest companies in the Pharmaceutical Product Manufacturing industry in Australia?
The biggest companies operating in the Pharmaceutical Product Manufacturing industry in Australia are AstraZeneca Holdings, Aspen Pharma and Viatris
What does the Pharmaceutical Product Manufacturing industry in Australia include?
Benefit-paid pharmaceuticals and Non-benefit paid pharmaceuticals are part of the Pharmaceutical Product Manufacturing industry in Australia.
Which companies have the highest market share in the Pharmaceutical Product Manufacturing industry in Australia?
The company holding the most market share in the Pharmaceutical Product Manufacturing industry in Australia is AstraZeneca Holdings.
How competitive is the Pharmaceutical Product Manufacturing industry in Australia?
The level of competition is high and increasing in the Pharmaceutical Product Manufacturing industry in Australia.
Cut through the noise with intelligence you can trust
